89 related articles for article (PubMed ID: 2105508)
21. Human immunodeficiency virus type 1 p24 production and antigenic variation in tissue culture of isolates with various growth characteristics.
Sundqvist VA; Albert J; Ohlsson E; Hinkula J; Fenyö EM; Wahren B
J Med Virol; 1989 Nov; 29(3):170-5. PubMed ID: 2482339
[TBL] [Abstract][Full Text] [Related]
22. Comparative assessment of antiretrovirals in human monocyte-macrophages and lymphoid cell lines acutely and chronically infected with the human immunodeficiency virus.
Crowe SM; McGrath MS; Elbeik T; Kirihara J; Mills J
J Med Virol; 1989 Nov; 29(3):176-80. PubMed ID: 2533247
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of HIV infectivity by lactoperoxidase-produced hypothiocyanite.
Pourtois M; Binet C; Van Tieghem N; Courtois P; Vandenabbeele A; Thiry L
J Biol Buccale; 1990 Dec; 18(4):251-3. PubMed ID: 2128884
[TBL] [Abstract][Full Text] [Related]
24. Human monoclonal antibodies to HIV-1: cross-reactions with gag and env products.
Pollock BJ; McKenzie AS; Kemp BE; McPhee DA; D'Apice AJ
Clin Exp Immunol; 1989 Dec; 78(3):323-8. PubMed ID: 2482145
[TBL] [Abstract][Full Text] [Related]
25. Effect of a single ethanol exposure on HIV replication in human lymphocytes.
Cook RT; Stapleton JT; Ballas ZK; Klinzman D
J Investig Med; 1997 Jun; 45(5):265-71. PubMed ID: 9249999
[TBL] [Abstract][Full Text] [Related]
26. Clinical value of HIV p24 Ag in cerebrospinal fluid of symptomatic or asymptomatic HIV-infected patients.
Carbonara S; Angarano G; Zimatore GB; Fiore JR; Laddago V; Santantonio T; Pastore G
Acta Neurol (Napoli); 1990 Feb; 12(1):44-8. PubMed ID: 2110716
[No Abstract] [Full Text] [Related]
27. Immunization of human HIV-seronegative volunteers with recombinant p17/p24:Ty virus-like particles elicits HIV-1 p24-specific cellular and humoral immune responses.
Martin SJ; Vyakarnam A; Cheingsong-Popov R; Callow D; Jones KL; Senior JM; Adams SE; Kingsman AJ; Matear P; Gotch FM
AIDS; 1993 Oct; 7(10):1315-23. PubMed ID: 8267904
[TBL] [Abstract][Full Text] [Related]
28. Fine specificity of IgG subclass response to group antigens in HIV-1-infected patients.
Broliden PA; Morfeldt-Månsson L; Rosen J; Jondal M; Wahren B
Clin Exp Immunol; 1989 May; 76(2):216-21. PubMed ID: 2503275
[TBL] [Abstract][Full Text] [Related]
29. [Production of recombinant proteins and their use in immunoblotting].
Farkhutdinov MR; Galiullin FG; Davletov EG; Gabbasov ShF; Safin BN
Vopr Med Khim; 1993; 39(3):60-2. PubMed ID: 8333196
[TBL] [Abstract][Full Text] [Related]
30. Saliva can contribute in quick inhibition of HIV infectivity.
Pourtois M; Binet C; Van Tieghem N; Courtois PR; Vandenabbeele A; Thirty L
AIDS; 1991 May; 5(5):598-600. PubMed ID: 1650564
[No Abstract] [Full Text] [Related]
31. Suppression of human immunodeficiency virus type 1 replication by human herpesvirus-6.
Carrigan DR; Knox KK; Tapper MA
J Infect Dis; 1990 Oct; 162(4):844-51. PubMed ID: 2169498
[TBL] [Abstract][Full Text] [Related]
32. Relationship between human immunodeficiency virus antigenemia and cytomegalovirus infection.
Lazzarotto T; Guan MX; Furlini G; Re MC; Ripalti A; Landini MP; La Placa M
Microbiologica; 1990 Jan; 13(1):61-5. PubMed ID: 2155377
[TBL] [Abstract][Full Text] [Related]
33. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.
Dis Markers; 1990; 8(3):164-5. PubMed ID: 2125538
[No Abstract] [Full Text] [Related]
34. MAP 30: a new inhibitor of HIV-1 infection and replication.
Lee-Huang S; Huang PL; Nara PL; Chen HC; Kung HF; Huang P; Huang HI; Huang PL
FEBS Lett; 1990 Oct; 272(1-2):12-8. PubMed ID: 1699801
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of HIV-1 proteins in Escherichia coli by a modified expression vector and their one-step purification.
Cheynet V; Verrier B; Mallet F
Protein Expr Purif; 1993 Oct; 4(5):367-72. PubMed ID: 8251747
[TBL] [Abstract][Full Text] [Related]
36. The tripeptide glycyl-prolyl-glycine amide does not affect the early steps of the human immunodeficiency virus type 1 replication.
Su J; Naghavi MH; Jejcic A; Horal P; Furuta Y; Wu YP; Li SL; Hall WW; Goobar-Larsson L; Svennerholm B; Vahlne A
J Hum Virol; 2001; 4(1):8-15. PubMed ID: 11213934
[TBL] [Abstract][Full Text] [Related]
37. Phenotypic mixing between human immunodeficiency virus and vesicular stomatitis virus or herpes simplex virus.
Zhu ZH; Chen SS; Huang AS
J Acquir Immune Defic Syndr (1988); 1990; 3(3):215-9. PubMed ID: 2154577
[TBL] [Abstract][Full Text] [Related]
38. Production of immunogenic HIV-1 viruslike particles in stably engineered monkey cell lines.
Haynes JR; Cao SX; Rovinski B; Sia C; James O; Dekaban GA; Klein MH
AIDS Res Hum Retroviruses; 1991 Jan; 7(1):17-27. PubMed ID: 1707639
[TBL] [Abstract][Full Text] [Related]
39. Expression and purification of p24, the core protein of HIV, using a baculovirus-insect cell expression system.
Mills HR; Jones IM
AIDS; 1990 Nov; 4(11):1125-31. PubMed ID: 2126440
[TBL] [Abstract][Full Text] [Related]
40. Rapid detection of HIV-1 in clinical samples by co-culture with heat-shocked cells.
Re MC; Furlini G; La Placa M
J Virol Methods; 1989 Dec; 26(3):313-7. PubMed ID: 2482842
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
